Related Posts
- Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy
Background Primary and secondary resistance is a major hurdle in cancer immunotherapy. Therefore, a better…
- [Corrections] Correction to Lancet Oncol 2021; 22: 74–84
Toi M, Imoto S, Ishida T, et al. Adjuvant S-1 plus endocrine therapy for oestrogen…
- [Corrections] Correction to Lancet Oncol 2023; 24: 228–38
Choueiri TK, Eto M, Motzer R, et al. Lenvatinib plus pembrolizumab versus sunitinib as first-line…